SearcharxivSearch

arXiv · 2512.06037

Evaluation of the infectivity of porcine epidemic diarrhea virus on swine vehicles after cleaning and disinfection

Abstract

Biosecurity measures enforced by the swine industry are in place not only to protect a single farm, but also the vast community of interconnected swine farms. Vehicles play a role in disease movement and given that most pigs move throughout the system multiple times during their lives, vehicle cleanliness is key to preventing disease spread. The objective of this study was to determine the infectivity of PEDV on various swine industry vehicles and evaluate the associated cleaning and disinfection (C&D) methods. Viral swabs were collected from various locations on swine industry vehicles and were used to make the bioassay inoculums which were given to a total of 54 piglets enrolled across two bioassays: a pilot bioassay to ensure the samples were collected and stored in a way that preserved the virus, and a full bioassay testing samples collected from vehicles post C&D. The piglets enrolled in the pilot bioassay tested positive for PEDV within 48 hours, confirming the methods were appropriate and capable of infecting piglets with PEDV. From the full bioassay, the piglets inoculated with samples collected from inside the pigs-to-market vehicle cabins experienced severe diarrhea and tested positive for PEDV. No other experimental treatment group experienced persistent clinical symptoms of PEDV in the full bioassay, suggesting the concentration of infectious PEDV remaining after C&D was not enough to cause severe PED in healthy piglets. However, the cleaning efficacy varied greatly across vehicle types, suggesting that producers should continue to uphold and improve vehicle C&D.

Explore related subjects

Keep this discovery

BibTeXRIS

Taylor B. Parker, Michael C. Rahe, Kelly A. Meiklejohn, Bradford Sean Darrow, Jason A. Galvis, Gustavo Machado, Juliana Bonin Ferreira. 2025-12-04. Evaluation of the infectivity of porcine epidemic diarrhea virus on swine vehicles after cleaning and disinfection. https://arxiv.org/abs/2512.06037

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

MarkerScout: A Disease-Agnostic Machine Learning Framework for Biomarker Prediction from Multi-Scale Mechanistic Models

We demonstrate the framework on three infectious diseases derived from a companion mechanistic immune-simulation platform: SARS-CoV-2, Influenza A Virus, and Plasmodium falciparum. Each disease was evaluated across hospitalization and intensive care unit cohorts, yielding six cohorts in total. Best-pipeline cross-validated macro F1 ranged from 0.82 for IAV-HOSP to 0.99 for COV-ICU, and the framework produced tiered, direction-aware biomarker lists for each disease and phase. Interleukin-18 (IL-18) reached the strongest tier in both SARS-CoV-2 phases with consistent direction. When benchmarked against three separate, independently collected clinical ICU datasets, MarkerScout's top-ranked features outperformed 94.4% of randomly selected feature sets of equivalent size for SARS-CoV-2, with a weaker but directionally consistent advantage for Influenza A Virus (66.7%) and Plasmodium falciparum (60.7%).

q-bio.OT

Enhancing Clinical Decision Support and Differential Diagnosis with Knowledge Graphs, and Retrieval Augmented Generation in Generative AI

Diagnostic error carries a burden, while unconstrained large language models (LLMs) remain vulnerable to hallucination and weak integration of quantitative laboratory dynamics. We developed a decision-support pipeline combining disease-specific biomarker correlation graphs, ordinary differential equations (ODEs), deep sequence classification, and retrieval-augmented generation (RAG). For 103 disease classes from a full blood count (FBC) repository, biomarker networks were used as coupling matrices to generate 30 trajectories per disease (3,090 total). A one-dimensional convolutional neural network (CNN) and long short-term memory (LSTM) network classified disease trajectories and six dynamical clusters. A constrained GPT-4o-mini RAG layer used a 19-pattern BMJ Best Practice/NICE corpus to generate differential diagnoses evaluated for diagnostic suitability, evidential grounding, and clinical plausibility. Across five random-seed runs, disease-level accuracy was $0.940 \pm 0.006$ for the CNN (95\% CI 0.933--0.948) and $0.852 \pm 0.019$ for the LSTM (95\% CI 0.828--0.875); the CNN advantage was 8.87 percentage points (95\% CI 6.47--11.27; $t(4)=10.26$, $p=5.1\times10^{-4}$; Hedges' $g=3.67$). Among 100 sampled RAG cases, 96 parsed successfully; evidence was cited in 97.9\%, the true diagnosis was mentioned in 71.9\%, and the composite score was 3.82/5 with a 47.9\% strict pass rate. The central finding was a decoupling between grounding and diagnostic correctness: classifier-correct versus classifier-wrong outputs differed in diagnostic suitability but not evidential grounding. Post-hoc analysis confirmed a 1.02-point diagnostic-score difference (Mann--Whitney $p=0.0024$; Hedges' $g=0.72$), whereas grounding differed by only $-0.02$ points ($p=0.839$; $g=-0.04$).

q-bio.OT

Expanding the Human Ancestry Ontology to include under-represented populations and ethnicities for broader utility in annotations

Successful discovery, integration and reuse of data relies on the availability of rich, well-structured and machine-readable metadata to describe every aspect of the data, from sample sources to collection processes to experimental protocols. The use of standardised terminologies to express concepts in a harmonised fashion lies at the core of high-quality data annotation, increasing the FAIRness of the data, facilitating data integration and promoting reproducibility. Here, we describe the Human Ancestry Ontology (HANCESTRO), originally developed to improve standardised reporting of genetic ancestry genomic resources such as the NHGRI-EBI GWAS Catalog and the Human Cell Atlas through high-level population descriptors, and more recently expanded to include diverse and previously under-represented populations in genomics and genetics research. HANCESTRO provides a framework for population descriptors that includes both ancestry based on the analysis of genetic information and self-reported ethnicity, which is based on social and cultural factors that don't necessarily align with genetic populations. By enabling the accurate and interoperable representation of population-related data, it promotes inclusive, representative and reproducible science.

q-bio.OT